首页 | 本学科首页   官方微博 | 高级检索  
     


Cost-effectiveness analysis of fecal microbiota transplantation for recurrent Clostridium difficile infection in patients with inflammatory bowel disease
Authors:Joyce H S You  Xinchan Jiang  Wally H Lee  Paul K S Chan  Siew C Ng
Affiliation:1. School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China;2. Department of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China

Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China

Centre for Gut Microbiota Research, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China;3. Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China

Centre for Gut Microbiota Research, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China

Division of Gastroenterology and Hepatology, Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China

Abstract:
Keywords:bezlotoxumab  cost-effectiveness analysis  fecal microbiota transplantation  fidaxomicin  inflammatory bowel disease  recurrent Clostridium difficile infection  vancomycin
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号